Specifically, we show that downregulation of DNASE1L3 in cancer, observed by others and in the present study, stems from specific downregulation of this gene in DCs (Figure 1C and Supplemental Figure 1C), the main cell type that physiologically expresses DNASE1L3. The gene discussed is DNASE1L3; the disease is cancer.